Your session is about to expire
← Back to Search
Other
Efficacy of Platelet Enriched Plasma in Preventing Surgery for Patients With Chronic Tympanic Membrane Perforation
Phase 1 & 2
Waitlist Available
Led By Hinrich Staecker, MD
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
No Placebo-Only Group
Summary
By doing this study, researchers hope to find out if platelet rich plasma (PRP) can heal holes in the eardrum as an alternative to surgery.
Eligible Conditions
- Ear Perforation
- Ear Drum Perforation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Prevention of Patients Requiring Surgery
Secondary study objectives
Time to Healing
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: PRP TreatmentExperimental Treatment1 Intervention
Participants receive platelet rich plasma treatment. Participants will be asked to make up to 5 trips to the clinic (one for eligibility, one for the PRP, three follow-up visits). Participation is expected to last up to about 6 weeks. After the second visit and application of PRP, patients will be monitored closely for any complications or concerns. This will include a follow up phone call 3-5 days after the initial application of PRP. Patients will also be followed closely in 2 week intervals or sooner should any problems or concerns arise.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Platelet Rich Plasma
2016
Completed Phase 4
~1100
Find a Location
Who is running the clinical trial?
University of Kansas Medical CenterLead Sponsor
517 Previous Clinical Trials
177,440 Total Patients Enrolled
Hinrich Staecker, MDPrincipal InvestigatorUniversity of Kansas Medical Center
1 Previous Clinical Trials
73 Total Patients Enrolled